Hong Kong Electrical Stock News

With a price-to-sales (or "P/S") ratio of 0.1x Golden Wheel Tiandi Holdings Company Limited ( HKG:1232 ) may be sending...

While China Renaissance Holdings Limited ( HKG:1911 ) shareholders have enjoyed a good week with stock up 14%, they...

It's nice to see the Zall Smart Commerce Group Ltd. ( HKG:2098 ) share price up 11% in a week. But will that heal all...

There wouldn't be many who think Century Energy International Holdings Limited's ( HKG:8132 ) price-to-sales (or "P/S...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

In late December 2025 and early January 2026, CSPC Pharmaceutical Group announced Chinese regulatory approvals to begin clinical trials for multiple innovative therapies, including an inhaled nintedanib for idiopathic pulmonary fibrosis, a novel aldosterone synthase inhibitor, a first-in-class diabetes triple-combination tablet, and a GLP‑1/GIP dual‑biased agonist injection for obesity. These clinical trial approvals highlight CSPC’s expanding innovation pipeline across respiratory,...

Key Insights Using the 2 Stage Free Cash Flow to Equity, MGM China Holdings fair value estimate is HK$23.25 MGM China...

Shandong Weigao Group Medical Polymer (HKG:1066) has had a rough three months with its share price down 12%. It is...

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. For example, we sympathize with anyone...

It is hard to get excited after looking at VSTECS Holdings' (HKG:856) recent performance, when its stock has declined...

Viewing insider transactions for China Medical System Holdings Limited's ( HKG:867 ) over the last year, we see that...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...

Shareholders appeared unconcerned with Edvantage Group Holdings Limited's ( HKG:382 ) lackluster earnings report last...

Key Insights E&P Global Holdings' significant individual investors ownership suggests that the key decisions are...

China Kepei Education Group Limited's ( HKG:1890 ) recent weak earnings report didn't cause a big stock movement. Our...

The China Chunlai Education Group Co., Ltd. ( HKG:1969 ) share price has fared very poorly over the last month, falling...

Tai Kam Holdings Limited ( HKG:8321 ) recently released a strong earnings report, and the market responded by raising...

Northeast Electric Development Company Limited's ( HKG:42 ) price-to-sales (or "P/S") ratio of 1.5x may not look like...

MGM China Holdings Limited ( HKG:2282 ) shareholders won't be pleased to see that the share price has had a very rough...

Looking at Kai Yuan Holdings Limited's ( HKG:1215 ) insider transactions over the last year, we can see that insiders...

Ascentage Pharma Group International recently reported that the US FDA has cleared its IND application for APG-3288, a next-generation BTK-targeted PROTAC degrader, allowing the company to begin clinical trials in patients with relapsed or refractory B-cell malignancies. This step not only extends Ascentage Pharma's efforts in targeted protein degradation but also responds to the medical need created by resistance to existing BTK inhibitors. We will now examine how FDA clearance for...